6,185,454 Shares of Common Stock 23,126 Shares of Series B Preferred Stock Viridian Therapeutics, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • September 23rd, 2021 • Viridian Therapeutics, Inc.\DE • Services-medical laboratories • New York
Contract Type FiledSeptember 23rd, 2021 Company Industry Jurisdiction